UK markets closed

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)

Milan - Milan Delayed price. Currency in EUR
Add to watchlist
49.98-2.62 (-4.98%)
At close: 05:35PM CEST
Full screen
Previous close52.60
Open53.00
Bid50.10 x 0
Ask50.15 x 0
Day's range49.90 - 53.40
52-week range40.00 - 53.40
Volume478,220
Avg. volume206,429
Market cap10.314B
Beta (5Y monthly)0.36
PE ratio (TTM)26.87
EPS (TTM)1.86
Earnings date09 May 2024
Forward dividend & yield1.26 (2.40%)
Ex-dividend date20 May 2024
1y target est51.20
  • Bloomberg

    CVC Explores Options for €11 Billion Drugmaker Recordati

    (Bloomberg) -- CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.Most Read from BloombergTaylor Swift Is Proof That How We Critique Music Is BrokenBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsBiden’s New Chopper Is Demoted After Scorching White House LawnTesla Soars as Musk’s Cheaper EVs Calm Fears Over StrategyThe buyout firm is working with advisers and is in the early

  • Reuters

    CVC explores options for Italy's Recordati, Bloomberg News reports

    CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018. Shares of Recordati have risen about 7.7% since the beginning of this year, giving the company a market capitalization of about 11 billion euros ($11.77 billion).

  • Reuters

    UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports

    CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.